Inventor · disambiguated record
Maximilian Woisetschlaeger
Also filed as: WOISETSCHLAEGER MAXIMILIAN
7 granted patents·10 pending applications·36 citations·filing 2009–2024
83Inventor score
Top patents by PatentIndex Score
17 records- 0191US10899841B2Anti-BAFFR antibody formulations and methods of use thereofNOVARTIS AG·Filed 2019·Granted Jan 26, 2021·3 cites·10 claims
- 0290US8106163B2Compositions and methods of use for therapeutic antibodiesHEUSSER CHRISTOPH·Filed 2009·Granted Jan 31, 2012·18 cites·13 claims
- 0389US9458240B2Anti-BAFFR antibody formulationsCOSENZA MARTA·Filed 2011·Granted Oct 4, 2016·8 cites·16 claims
- 0487US2025163170A1Antibody formulationNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0584US2025034270A1Compositions and methods of use for therapeutic antibodiesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0681US9340620B2Compositions and methods of use for therapeutic antibodiesHEUSSER CHRISTOPH·Filed 2011·Granted May 17, 2016·5 cites·5 claims
- 0775US12054555B2Anti-BAFFR antibody formulations and methods of use thereofNOVARTIS AG·Filed 2020·Granted Aug 6, 2024·0 cites·10 claims
- 0874US9382326B2Compositions and methods of use for therapeutic antibodiesHEUSSER CHRISTOPH·Filed 2011·Granted Jul 5, 2016·2 cites·10 claims
- 0974US2024425617A1Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodiesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1072US2022298251A1Compositions and methods of use for therapeutic antibodiesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1169US2018179290A1Antibody formulationNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1263US11987644B2Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodiesNOVARTIS AG·Filed 2020·Granted May 21, 2024·0 cites·4 claims
- 1363US2016368999A1Antibody formulationCOSENZA MARTA·Filed 2016·Application pending·0 cites
- 1460US2019135931A1Compositions and methods of use for therapeutic antibodiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1552US2016347851A1Compositions and methods of use for therapeutic antibodiesHEUSSER CHRISTOPH·Filed 2016·Application pending·0 cites
- 1649US2011237498A1Soluble polypeptides for use in treating autoimmune and inflammatory disordersNOVARTIS AG·Filed 2009·Application pending·0 cites
- 1749US2019002589A1Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodiesNOVARTIS AG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maximilian Woisetschlaeger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →